Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Case Western Reserve University · with Crohn's and Colitis Foundation · NCT07852273
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–75 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 40
- US sites recruiting
- 3
- Study start
- April 18, 2024
- Record last updated
- October 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will focus on the commonly used non-nutritive sweetener (NNS) sucralose (2 sachets/day resulting in daily dose: sucralose 2.5mg/kg) and its role in changing the gut microbiota in humans with Inflammatory Bowel Disease (IBD), compared to healthy non-IBD individuals. We will focus on studying IBD patients affected with Crohn's Disease (CD) as a proof of principle that could be tested later in other IBD subtypes (ulcerative colitis or others specific surgical conditions).
Being studied: Sucralose (non-nutritive sweetener)
Conditions: Inflamatory Bowel Disease; Crohn Disease (CD)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age range from 18 to 75 years
- Male or female
- Documented diagnosis of Crohns disease. CD outpatients in remission; Harvey Bradshaw- index in remission (\<6 score)
- Capable of providing consent to participate.
- Able to complete daily surveys and take oral nutrition
- Able to record meal intake
- Healthy controls with no diagnosis of Irritable Bowel Disease IBD or Irritable Bowel Syndrome (IBS)
Exclusion Criteria
- Short bowel syndrome
- Hospitalized patients
- Individuals who lack consent capacity, including the mentally ill, prisoners, cognitively impaired participants, dementia patients
- Known drug abuse
- Known parasitic disease of the digestive system
- Symptomatic intestinal stricture/narrowing
- Presence of an ostomy
- Known active malignancy
- Antibiotic use within last 14 days
- Well-founded doubt about the patient's cooperation.
- Existing pregnancy or lactation
- History of \<1 natural bowel movements per 3 consecutive days
- Unable to access technology that permits the daily completion of study related activities
- Change in IBD medication within past 4 weeks
- Body mass Index \<16 kg/m or ≥40 kg/m
- Documented C.difficile colitis within four weeks of screening
- Bariatric surgery
- Phenylketonuria
Recruiting US locations
UH Minoff Health Center
Chagrin Falls, OH 44122
Site contact: Abigail Basson, RD PhD · Abigail.Basson@uhhospitals.org
University Hospitals Cleveland Medical Center
Cleveland, OH 44106
Site contact: Abigail Basson, RD PhD · 1-888-844-8447 · Abigail.Basson@uhhospitals.org
UH Westlake Health Center
Westlake, OH 44145
Site contact: Abigail Basson, RD PhD · Abigail.Basson@uhhospitals.org
Study contacts (from the official record)
- Sargun Singh, M.B.B.S. · 216-333-6085 · sks197@case.edu
- Abigail Raffner, RD, PhD · 216-327-6003 · Abigail.Raffner@uhhospiatls.org
Similar studies in Ohio
All healthy volunteers studies in Ohio →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Hanmi Pharmaceutical Company Limited
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
LH-001 vs Placebo in Healthy Participants
Chien-Liang Lin
- Location
- Columbus, OH
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Beachwood, OH + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 50–75